Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens
Mark L Gonzalgo, Christian P Pavlovich, Shing M Lee, et al.
Clinical Trials (London, England)
|
July 5, 2021
What do we do with our under-enrolled single-center COVID-19 clinical trials?
Shing M Lee, Denise Esserman, Ken Cheung, et al.
Cancer Investigation
|
July 11, 2017
Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib
Shing M Lee, Yuan Zhang, Lori M Minasian, et al.
Health and Quality of Life Outcomes
|
August 24, 2019
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events
Shing M Lee, Jieling Miao, Ruby Wu, et al.
Obstetrics and Gynecology
|
June 3, 2008
Transcervical Foley catheter with and without oxytocin for cervical ripening: a randomized controlled trial
Christian M Pettker, Sean B Pocock, Dorothy P Smok, et al.
Urology
|
February 20, 2004
Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis
Mark L Gonzalgo, Masashi Nakayama, Shing M Lee, et al.
Journal of Oncology Practice
|
February 25, 2016
Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events
Xiaobo Zhong, Emerson A Lim, Dawn L Hershman, et al.
Chest
|
May 13, 2003
Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema
Zab Mohsenifar, Shing M Lee, Philip Diaz, et al.
Journal of the American Medical Informatics Association : JAMIA
|
August 5, 2021
Misalignment between COVID-19 hotspots and clinical trial sites
Lauren Franks, Hao Liu, Mitchell S V Elkind, et al.
Statistics in Medicine
|
February 20, 2016
Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration
Graham M Wheeler, Michael J Sweeting, Adrian P Mander, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens
Mark L Gonzalgo, Christian P Pavlovich, Shing M Lee, et al.
Clinical Trials (London, England)
|
July 5, 2021
What do we do with our under-enrolled single-center COVID-19 clinical trials?
Shing M Lee, Denise Esserman, Ken Cheung, et al.
Cancer Investigation
|
July 11, 2017
Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib
Shing M Lee, Yuan Zhang, Lori M Minasian, et al.
Health and Quality of Life Outcomes
|
August 24, 2019
A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events
Shing M Lee, Jieling Miao, Ruby Wu, et al.
Obstetrics and Gynecology
|
June 3, 2008
Transcervical Foley catheter with and without oxytocin for cervical ripening: a randomized controlled trial
Christian M Pettker, Sean B Pocock, Dorothy P Smok, et al.
Urology
|
February 20, 2004
Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis
Mark L Gonzalgo, Masashi Nakayama, Shing M Lee, et al.
Journal of Oncology Practice
|
February 25, 2016
Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events
Xiaobo Zhong, Emerson A Lim, Dawn L Hershman, et al.
Chest
|
May 13, 2003
Single-breath diffusing capacity of the lung for carbon monoxide: a predictor of PaO2, maximum work rate, and walking distance in patients with emphysema
Zab Mohsenifar, Shing M Lee, Philip Diaz, et al.
Journal of the American Medical Informatics Association : JAMIA
|
August 5, 2021
Misalignment between COVID-19 hotspots and clinical trial sites
Lauren Franks, Hao Liu, Mitchell S V Elkind, et al.
Statistics in Medicine
|
February 20, 2016
Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration
Graham M Wheeler, Michael J Sweeting, Adrian P Mander, et al.
Page
of 7